SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-17-002511
Filing Date
2017-04-07
Accepted
2017-04-07 08:30:18
Documents
9
Period of Report
2017-05-24
Effectiveness Date
2017-04-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A axgn-20170524xdef14a.htm DEF 14A 1104157
2 GRAPHIC axgn20170524xdef14a001.jpg GRAPHIC 25124
3 GRAPHIC axgn20170524xdef14a002.jpg GRAPHIC 10908
4 GRAPHIC axgn20170524xdef14a003.jpg GRAPHIC 3450
5 GRAPHIC axgn20170524xdef14a004.gif GRAPHIC 78369
6 GRAPHIC axgn20170524xdef14a005.gif GRAPHIC 42296
7 GRAPHIC axgn20170524xdef14a006.gif GRAPHIC 31468
8 GRAPHIC axgn20170524xdef14a007.gif GRAPHIC 48233
9 GRAPHIC axgn20170524xdef14a008.gif GRAPHIC 104062
  Complete submission text file 0001558370-17-002511.txt   1574668
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
AxoGen, Inc. (Filer) CIK: 0000805928 (see all company filings)

IRS No.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36046 | Film No.: 17747718
SIC: 3845 Electromedical & Electrotherapeutic Apparatus